FDA Warns Manufacturers of Products Labeled as Homeopathic for Putting Consumers at Risk with Significant Violations of Manufacturing Quality Standards

May 14, 2019 -- The U.S. Food and Drug Administration has posted warning letters to five companies who produce products labeled as homeopathic for significant violations of current good manufacturing practice (CGMP) regulations. Four of the warning...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news